Annual FCF
-$25.32 M
+$309.30 K+1.21%
31 December 2023
Summary:
SAB Biotherapeutics annual free cash flow is currently -$25.32 million, with the most recent change of +$309.30 thousand (+1.21%) on 31 December 2023. During the last 3 years, it has fallen by -$22.59 million (-828.40%). SABS annual FCF is now -828.40% below its all-time high of -$2.73 million, reached on 31 December 2020.SABS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$6.39 M
+$1.38 M+17.73%
30 September 2024
Summary:
SAB Biotherapeutics quarterly free cash flow is currently -$6.39 million, with the most recent change of +$1.38 million (+17.73%) on 30 September 2024. Over the past year, it has dropped by -$1.14 million (-21.69%). SABS quarterly FCF is now -184.52% below its all-time high of $7.56 million, reached on 31 March 2021.SABS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$38.56 M
-$1.14 M-3.04%
30 September 2024
Summary:
SAB Biotherapeutics TTM free cash flow is currently -$38.56 million, with the most recent change of -$1.14 million (-3.04%) on 30 September 2024. Over the past year, it has dropped by -$25.08 million (-186.14%). SABS TTM FCF is now -609.78% below its all-time high of $7.56 million, reached on 31 March 2021.SABS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.2% | -21.7% | -186.1% |
| 3 y3 years | -828.4% | -1222.8% | -2145.9% |
| 5 y5 years | - | - | - |
SABS Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -828.4% | +1.2% | -1222.8% | +52.7% | -2145.9% | at low |
| 5 y | 5 years | -828.4% | +1.2% | -184.5% | +52.7% | -609.8% | at low |
| alltime | all time | -828.4% | +1.2% | -184.5% | +52.7% | -609.8% | at low |
SAB Biotherapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.39 M(-17.7%) | -$38.56 M(+3.0%) |
| June 2024 | - | -$7.77 M(-28.6%) | -$37.42 M(+8.2%) |
| Mar 2024 | - | -$10.88 M(-19.5%) | -$34.57 M(+36.5%) |
| Dec 2023 | -$25.32 M(-1.2%) | -$13.51 M(+157.3%) | -$25.32 M(+87.9%) |
| Sept 2023 | - | -$5.25 M(+6.7%) | -$13.47 M(-16.9%) |
| June 2023 | - | -$4.92 M(+202.5%) | -$16.22 M(-0.9%) |
| Mar 2023 | - | -$1.63 M(-2.7%) | -$16.36 M(-36.2%) |
| Dec 2022 | -$25.63 M | -$1.67 M(-79.1%) | -$25.63 M(-17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$8.00 M(+58.0%) | -$31.19 M(+37.9%) |
| June 2022 | - | -$5.06 M(-53.5%) | -$22.63 M(-17.5%) |
| Mar 2022 | - | -$10.89 M(+50.5%) | -$27.42 M(+206.1%) |
| Dec 2021 | -$8.96 M(+228.5%) | -$7.24 M(-1371.8%) | -$8.96 M(+421.7%) |
| Sept 2021 | - | $569.30 K(-105.8%) | -$1.72 M(-24.9%) |
| June 2021 | - | -$9.85 M(-230.2%) | -$2.29 M(-130.2%) |
| Mar 2021 | - | $7.56 M | $7.56 M |
| Dec 2020 | -$2.73 M(-72.2%) | - | - |
| Dec 2019 | -$9.82 M | - | - |
FAQ
- What is SAB Biotherapeutics annual free cash flow?
- What is the all time high annual FCF for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual FCF year-on-year change?
- What is SAB Biotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly FCF year-on-year change?
- What is SAB Biotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for SAB Biotherapeutics?
- What is SAB Biotherapeutics TTM FCF year-on-year change?
What is SAB Biotherapeutics annual free cash flow?
The current annual FCF of SABS is -$25.32 M
What is the all time high annual FCF for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual free cash flow is -$2.73 M
What is SAB Biotherapeutics annual FCF year-on-year change?
Over the past year, SABS annual free cash flow has changed by +$309.30 K (+1.21%)
What is SAB Biotherapeutics quarterly free cash flow?
The current quarterly FCF of SABS is -$6.39 M
What is the all time high quarterly FCF for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly free cash flow is $7.56 M
What is SAB Biotherapeutics quarterly FCF year-on-year change?
Over the past year, SABS quarterly free cash flow has changed by -$1.14 M (-21.69%)
What is SAB Biotherapeutics TTM free cash flow?
The current TTM FCF of SABS is -$38.56 M
What is the all time high TTM FCF for SAB Biotherapeutics?
SAB Biotherapeutics all-time high TTM free cash flow is $7.56 M
What is SAB Biotherapeutics TTM FCF year-on-year change?
Over the past year, SABS TTM free cash flow has changed by -$25.08 M (-186.14%)